{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T10:05:01Z","timestamp":1772532301980,"version":"3.50.1"},"reference-count":36,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ataxia is a common clinical feature in inherited metabolic disorders. There are more than 150 inherited metabolic disorders in patients presenting with ataxia in addition to global developmental delay, encephalopathy episodes, a history of developmental regression, coarse facial features, seizures, and other types of movement disorders. Seizures and a history of developmental regression especially are important clinical denominators to consider an underlying inherited metabolic disorder in a patient with ataxia. Some of the inherited metabolic disorders have disease specific treatments to improve outcomes or prevent early death. Early diagnosis and treatment affect positive neurodevelopmental outcomes, so it is important to think of inherited metabolic disorders in the differential diagnosis of ataxia.<\/jats:p>","DOI":"10.3390\/ijms21155519","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T06:16:47Z","timestamp":1596435407000},"page":"5519","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Inherited Metabolic Disorders Presenting with Ataxia"],"prefix":"10.3390","volume":"21","author":[{"given":"Grace","family":"Silver","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON M5S 1A8, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saadet","family":"Mercimek-Andrews","sequence":"additional","affiliation":[{"name":"Division of Clinical and Metabolic Genetics, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada"},{"name":"Department of Paediatrics, University of Toronto, Toronto, ON M5G 1X8, Canada"},{"name":"Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejpn.2007.07.010","article-title":"Differential diagnosis of cerebellar atrophy in childhood","volume":"12","author":"Poretti","year":"2008","journal-title":"Eur. J. Paediatr. Neurol. EJPN Off. J. Eur. Paediatr. Neurol. Soc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.nic.2016.03.007","article-title":"The Pediatric Cerebellum in Inherited Neurodegenerative Disorders: A Pattern-recognition Approach","volume":"26","author":"Blaser","year":"2016","journal-title":"Neuroimaging Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ncl.2014.09.004","article-title":"Ataxia","volume":"33","author":"Akbar","year":"2015","journal-title":"Neurol. Clin."},{"key":"ref_4","first-page":"1208","article-title":"Ataxia","volume":"22","author":"Ashizawa","year":"2016","journal-title":"Contin. Minneap. Minn"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ymgme.2019.03.007","article-title":"Clinical and biochemical footprints of inherited metabolic diseases. I. Movement disorders","volume":"127","author":"Ferreira","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1212\/NXG.0000000000000265","article-title":"Genetic landscape of pediatric movement disorders and management implications","volume":"4","author":"Cordeiro","year":"2018","journal-title":"Neurol. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Pode-Shakked, N., Korman, S.H., Pode-Shakked, B., Landau, Y., Kneller, K., Abraham, S., Shaag, A., Ulanovsky, I., Daas, S., and Saraf-Levy, T. (2020). Clues and challenges in the diagnosis of intermittent maple syrup urine disease. Eur. J. Med. Genet., 103901.","DOI":"10.1016\/j.ejmg.2020.103901"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/TACG.S125962","article-title":"Maple syrup urine disease: Mechanisms and management","volume":"10","author":"Blackburn","year":"2017","journal-title":"Appl. Clin. Genet."},{"key":"ref_9","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J., Stephens, K., and Amemiya, A. (1993). Maple Syrup Urine Disease. GeneReviews\u00ae, University of Washington."},{"key":"ref_10","first-page":"1","article-title":"Friedreich Ataxia in Classical Galactosaemia","volume":"26","author":"Neville","year":"2016","journal-title":"JIMD Rep."},{"key":"ref_11","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J., Stephens, K., and Amemiya, A. (1993). Classic Galactosemia and Clinical Variant Galactosemia. GeneReviews\u00ae, University of Washington."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1007\/s00431-003-1352-2","article-title":"Early diagnosis of inherited metabolic disorders towards improving outcome: The controversial issue of galactosaemia","volume":"162","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"ref_13","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J., Stephens, K., and Amemiya, A. (1993). Glucose Transporter Type 1 Deficiency Syndrome. GeneReviews\u00ae, University of Washington."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/mds.22808","article-title":"The spectrum of movement disorders in Glut-1 deficiency","volume":"25","author":"Pons","year":"2010","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"ref_15","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J., Stephens, K., and Amemiya, A. (1993). Creatine Deficiency Syndromes. GeneReviews\u00ae, University of Washington."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejpn.2018.02.007","article-title":"Treatment outcome of twenty-two patients with guanidinoacetate methyltransferase deficiency: An international retrospective cohort study","volume":"22","author":"Khaikin","year":"2018","journal-title":"Eur. J. Paediatr. Neurol. EJPN Off. J. Eur. Paediatr. Neurol. Soc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ymgme.2008.10.008","article-title":"Expanded clinical and molecular spectrum of guanidinoacetate methyltransferase (GAMT) deficiency","volume":"96","author":"Dhar","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/jmedgenet-2013-101658","article-title":"Phenotype and genotype in 101 males with X-linked creatine transporter deficiency","volume":"50","author":"Betsalel","year":"2013","journal-title":"J. Med. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10545-014-9749-9","article-title":"Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency","volume":"38","author":"Desbats","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_20","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J., Stephens, K., and Amemiya, A. (1993). Primary Coenzyme Q10 Deficiency. GeneReviews\u00ae, University of Washington."},{"key":"ref_21","first-page":"219","article-title":"Biotinidase Deficiency: A Treatable Neurological Inborn Error of Metabolism","volume":"21","author":"Hayek","year":"2019","journal-title":"Isr. Med. Assoc. J. IMAJ"},{"key":"ref_22","first-page":"464","article-title":"Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee Technical standards and guidelines for the diagnosis of biotinidase deficiency","volume":"12","author":"Cowan","year":"2010","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"ref_23","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J., Stephens, K., and Amemiya, A. (1993). Biotinidase Deficiency. GeneReviews\u00ae, University of Washington."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jimd.12053","article-title":"An update on the genetics, clinical presentation, and pathomechanisms of human riboflavin transporter deficiency","volume":"42","author":"Bosch","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ajmg.a.38530","article-title":"Riboflavin transporter deficiency mimicking mitochondrial myopathy caused by complex II deficiency","volume":"176","author":"Nimmo","year":"2018","journal-title":"Am. J. Med. Genet. A."},{"key":"ref_26","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J., Stephens, K., and Amemiya, A. (1993). Neuronal Ceroid-Lipofuscinoses. GeneReviews\u00ae, University of Washington."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","article-title":"Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis","volume":"18","author":"Mole","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.bbadis.2013.04.008","article-title":"NCL diseases-clinical perspectives","volume":"1832","author":"Schulz","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neuroscience.2019.08.016","article-title":"Clinical Application of Targeted Next-Generation Sequencing Panels and Whole Exome Sequencing in Childhood Epilepsy","volume":"418","author":"Costain","year":"2019","journal-title":"Neuroscience"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of Intraventricular Cerliponase Alfa for CLN2 Disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_31","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J., Stephens, K., and Amemiya, A. (1993). X-Linked Adrenoleukodystrophy. GeneReviews\u00ae, University of Washington."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11940-019-0605-y","article-title":"The Landscape of Hematopoietic Stem Cell Transplant and Gene Therapy for X-Linked Adrenoleukodystrophy","volume":"21","author":"Mallack","year":"2019","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_33","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J., Stephens, K., and Amemiya, A. (2020, June 12). Ataxia with Vitamin E Deficiency, GeneReviews\u00ae, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1241\/."},{"key":"ref_34","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J., Stephens, K., and Amemiya, A. (2020, June 12). Abetalipoproteinemia, GeneReviews\u00ae, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532447\/."},{"key":"ref_35","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J., Stephens, K., and Amemiya, A. (2020, June 12). Refsum Disease, GeneReviews\u00ae, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1353\/."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1542\/peds.2008-3724","article-title":"Failure to thrive: When to suspect inborn errors of metabolism","volume":"124","author":"Ficicioglu","year":"2009","journal-title":"Pediatrics."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/15\/5519\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:53:39Z","timestamp":1760176419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/15\/5519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":36,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["ijms21155519"],"URL":"https:\/\/doi.org\/10.3390\/ijms21155519","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,1]]}}}